National Cancer Institute, Bethesda, MD, USA.
Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA.
Qual Life Res. 2021 Apr;30(4):1131-1143. doi: 10.1007/s11136-020-02683-3. Epub 2020 Nov 2.
Health-related quality of life (HRQOL) among older cancer survivors can be impaired by factors such as treatment, comorbidities, and social challenges. These HRQOL impairments may be especially pronounced in rural areas, where older adults have higher cancer burden and more comorbidities and risk factors for poor health. This study aimed to assess rural-urban differences in HRQOL for older cancer survivors and controls.
Data came from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey (SEER-MHOS), which links cancer incidence from 18 U.S. population-based cancer registries to survey data for Medicare Advantage Organization enrollees (1998-2014). HRQOL measures were 8 standardized subscales and 2 global summary measures. We matched (2:1) controls to breast, colorectal, lung, and prostate cancer survivors, creating an analytic dataset of 271,640 participants (ages 65+). HRQOL measures were analyzed with linear regression models including multiplicative interaction terms (rurality by cancer status), controlling for sociodemographics, cohort, and multimorbidities.
HRQOL scores were higher in urban than rural areas (e.g., global physical component summary score for breast cancer survivors: urban mean = 38.7, standard error [SE] = 0.08; rural mean = 37.9, SE = 0.32; p < 0.05), and were generally lower among cancer survivors compared to controls. Rural cancer survivors had particularly poor vitality (colorectal: p = 0.05), social functioning (lung: p = 0.05), role limitation-physical (prostate: p < 0.01), role limitation-emotional (prostate: p < 0.01), and global mental component summary (prostate: p = 0.02).
Supportive interventions are needed to increase physical, social, and emotional HRQOL among older cancer survivors in rural areas. These interventions could target cancer-related stigma (particularly for lung and prostate cancers) and/or access to screening, treatment, and ancillary healthcare resources.
健康相关生活质量(HRQOL)在老年癌症幸存者中可能会因治疗、合并症和社会挑战等因素而受损。这些 HRQOL 损害在农村地区可能更为明显,那里的老年人癌症负担更高,合并症更多,健康状况不良的风险因素也更多。本研究旨在评估农村和城市地区老年癌症幸存者和对照组之间的 HRQOL 差异。
数据来自监测、流行病学和最终结果-医疗保险健康结果调查(SEER-MHOS),该调查将美国 18 个人群为基础的癌症登记处的癌症发病率与医疗保险优势组织参保人(1998-2014 年)的调查数据相链接。HRQOL 测量指标包括 8 个标准化子量表和 2 个总体综合测量指标。我们以 2:1 的比例匹配了对照组和乳腺癌、结直肠癌、肺癌和前列腺癌幸存者,创建了一个包含 271640 名参与者(年龄在 65 岁以上)的分析数据集。通过线性回归模型分析 HRQOL 测量指标,该模型包括乘法交互项(农村和城市的癌症状况),并控制了社会人口统计学、队列和多种合并症。
城市地区的 HRQOL 评分高于农村地区(例如,乳腺癌幸存者的总体身体成分综合评分:城市平均得分=38.7,标准误差[SE]=0.08;农村平均得分=37.9,SE=0.32;p<0.05),而且癌症幸存者的 HRQOL 评分通常低于对照组。与对照组相比,农村癌症幸存者的活力(结直肠癌:p=0.05)、社会功能(肺癌:p=0.05)、身体角色限制(前列腺癌:p<0.01)、情绪角色限制(前列腺癌:p<0.01)和总体心理成分综合评分(前列腺癌:p=0.02)尤其差。
需要采取支持性干预措施来提高农村地区老年癌症幸存者的身体、社会和情绪 HRQOL。这些干预措施可以针对癌症相关的耻辱感(特别是肺癌和前列腺癌)和/或获得筛查、治疗和辅助医疗资源的机会。